Testosterone replacement therapy increase risks of CV events

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1764卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65437-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：13 / 13

相关论文

共 50 条

[41] Testosterone-Replacement Therapy
Swerdloff, Ronald
Anawalt, Bradley D.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21): : 2032 - 2034
[42] Safety of Testosterone Replacement Therapy
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1490): : 33 - 34
[43] Testosterone replacement therapy Preface
Shoskes, Daniel A.
Hakim, Lawrence S.
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 812 - 813
[44] Testosterone - not just a replacement therapy
Jackson, Graham
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) : 1021 - 1022
[45] Testosterone replacement therapy for anxiety
Cooper, MA
Ritchie, EC
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (11): : 1884 - 1884
[46] Saxagliptin does not increase risk of CV events
Reactions Weekly, 2015, 1578 (1) : 10 - 10
[47] Testosterone replacement therapy and the prostate
Tenover J.L.
Current Sexual Health Reports, 2007, 4 (2) : 79 - 82
[48] INCREASED RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN TESTOSTERONE DEFICIENT MEN AND IN MEN RECEIVING TESTOSTERONE REPLACEMENT THERAPY
Mann, U.
Bal, D.
Brar, R.
Patel, P.
JOURNAL OF SEXUAL MEDICINE, 2023, 20
[49] Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels
Kumanov, Philip
Tomova, Analia
Kirilov, Georgi
INTERNATIONAL JOURNAL OF ANDROLOGY, 2007, 30 (01): : 41 - 47
[50] New evidence of CV risk with testosterone therapy
Reactions Weekly, 2014, 1484 (1) : 3 - 3

← 1 2 3 4 5 →